Upper tract tumors in patients with primary bladder cancer followed for 15 years

Harry W. Herr, Michael S. Cookson, Scott M. Soloway

Research output: Contribution to journalArticlepeer-review

85 Scopus citations

Abstract

Purpose: We evaluated the long-term incidence of upper tract tumors in patients with primary superficial bladder cancer. Materials and Methods: A total of 86 patients with stages Ta, T1 and Tis bladder tumors, who were entered into a prospective trial of bacillus Calmette-Guerin between 1978 and 1981, was followed for 15 years or longer. Results: Of the 86 patients 18 (21%) had upper tract tumors after a median interval of 7.3 years (range 1 to 15). Tumors occurred within 5 years of followup in 6 cases, between 5 and 10 years in 7, and between 10 and 15 years in 5. The majority of cancers were invasive and 7 patients died of upper tract tumors. Conclusions: Patients with primary bladder tumors are at risk for upper urinary tract disease for up to 15 years, which suggests the need for lifelong regular upper tract monitoring in these cases.

Original languageEnglish (US)
Pages (from-to)1286-1287
Number of pages2
JournalJournal of Urology
Volume156
Issue number4
DOIs
StatePublished - Oct 1996

Keywords

  • BCG vaccine
  • bladder neoplasms
  • kidney neoplasms
  • ureteral neoplasms
  • urinary tract

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Upper tract tumors in patients with primary bladder cancer followed for 15 years'. Together they form a unique fingerprint.

Cite this